DreaMed Diabetes Raises $3.3M

July 25, 2016 | Israeli startup DreaMed Diabetes, which develops diabetes treatment and management solutions, announced today that it has raised $3.3 million from Norma Investments Limited, representing businessman Roman Abramovich, and a strategic investor. The funds will be used mainly for the further development of Advisor, DreaMed Diabetes’s decision support technology platform for determining the optimal patient-specific insulin treatment plans leading to balanced glucose levels in people with diabetes. Based in Petah Tikva, the company was founded in 2014 by Eran Atlas and Shahar Miller.